Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment

被引：0
|
作者：
Ruiwen Ruan
Li Li
Xuan Li
Chunye Huang
Zhanmin Zhang
Hongguang Zhong
Shaocheng Zeng
Qianqian Shi
Yang Xia
Qinru Zeng
Qin Wen
Jingyi Chen
Xiaofeng Dai
Jianping Xiong
Xiaojun Xiang
Wan Lei
Jun Deng
机构：
[1] First Affiliated Hospital of Nanchang University,Department of Oncology
[2] Jiangxi Key Laboratory for lndividualized Cancer Therapy,undefined
来源：
Molecular Cancer | / 22卷
关键词：
Fibroblast growth factor receptor; Immune checkpoint blockade; Tumor microenvironment; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy
    Lu, Chia-Sing
    Lin, Ching-Wen
    Chang, Ya-Hsuan
    Chen, Hsuan-Yu
    Chung, Wei-Chia
    Lai, Wei-Yun
    Ho, Chao-Chi
    Wang, Tong-Hong
    Chen, Chi-Yuan
    Yeh, Chen-Lin
    Wu, Sean
    Wang, Shu-Ping
    Yang, Pan-Chyr
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [22] Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
    Genova, Carlo
    Dellepiane, Chiara
    Carrega, Paolo
    Sommariva, Sara
    Ferlazzo, Guido
    Pronzato, Paolo
    Gangemi, Rosaria
    Filaci, Gilberto
    Coco, Simona
    Croce, Michela
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [23] Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade
    Fang, Tianxu
    Cao, Xiaona
    Wang, Li
    Chen, Mo
    Deng, Yueyang
    Chen, Guojun
    BIOACTIVE MATERIALS, 2024, 32 : 530 - 542
  • [24] Repurposing macitentan with nanoparticle modulates tumor microenvironment to potentiate immune checkpoint blockade
    Son, Soyoung
    Shin, Jung Min
    Shin, Sol
    Kim, Chan Ho
    Lee, Jae Ah
    Ko, Hyewon
    Lee, Eun Sook
    Jung, Jae Min
    Kim, Jeongyun
    Park, Jae Hyung
    BIOMATERIALS, 2021, 276 (276)
  • [25] Pan-FGFR Inhibition Leads to Blockade of FGF23 Signaling, Soft Tissue Mineralization, and Cardiovascular Dysfunction
    Yanochko, Gina M.
    Vitsky, Allison
    Heyen, Jonathan R.
    Hirakawa, Brad
    Lam, Justine L.
    May, Jeff
    Nichols, Tim
    Sace, Frederick
    Trajkovic, Dusko
    Blasi, Eileen
    TOXICOLOGICAL SCIENCES, 2013, 135 (02) : 451 - 464
  • [26] Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy
    Lee, Yu-Hung
    Yu, Ching-Fang
    Yang, Ying-Chieh
    Hong, Ji-Hong
    Chiang, Chi-Shiun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 14
  • [27] Lenvatinib suppress FGF19-FGFR4 signaling to enhance antitumor immune response in gastric cancer
    Maruyama, Yuya
    Saito, Motonobu
    Nakajima, Shotaro
    Saito, Katsuharu
    Suzuki, Hiroya
    Kanoda, Ryo
    Okayama, Hirokazu
    Hanayama, Hiroyuki
    Sakamoto, Wataru
    Saze, Zenichiro
    Momma, Tomoyuki
    Mimura, Kosaku
    Goto, Akiteru
    Kono, Koji
    GASTRIC CANCER, 2025, : 397 - 408
  • [28] Antibody mediated blockade of phosphatidylserine to enhance immune checkpoint blockade by repolarizing immune suppressive mechanisms of the tumor microenvironment.
    Hutchins, Jeff
    Gray, Michael J.
    Huang, Xianming
    Gong, Jian
    Hatch, Michaela M. S.
    Van Nguyen
    Hughes, Christopher C. W.
    Brekken, Rolf A.
    Freimark, Bruce D.
    Gerber, David E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Dual roles of endothelial FGF-2–FGFR1–PDGF-BB and perivascular FGF-2–FGFR2–PDGFRβ signaling pathways in tumor vascular remodeling
    Kayoko Hosaka
    Yunlong Yang
    Masaki Nakamura
    Patrik Andersson
    Xiaojuan Yang
    Yin Zhang
    Takahiro Seki
    Martin Scherzer
    Olivier Dubey
    Xinsheng Wang
    Yihai Cao
    Cell Discovery, 4
  • [30] Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
    Harber, James
    Kamata, Tamihiro
    Pritchard, Catrin
    Fennell, Dean
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
12345